ORIC Pharmaceuticals, Inc.ORICNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +22.89% | +22.95% | +5.48% | +11.06% | +40.28% |
| Weighted Average Shares Diluted Growth | +22.89% | +22.95% | +5.48% | +11.06% | +40.27% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +10.11% | +7.64% | -30.77% | +5.46% | +42.75% |
| Book Value per Share Growth | -9.89% | -11.76% | -36.61% | -3.53% | +5.87% |
| Debt Growth | +14.41% | -68.83% | +15.78% | +18.16% | +5.77% |
| R&D Expense Growth | +39.37% | +30.59% | +12.20% | +5.56% | -7.78% |
| SG&A Expenses Growth | +13.06% | +9.16% | +19.34% | +20.32% | +10.99% |